Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years
Conditions: Influenza; Pneumonia; Lower Respiratory Tract Infection; Acute Myocardial Infarction; Congestive Heart Failure; Stroke Interventions: Biological: Flublok Quadrivalent; Biological: Standard Dose Inactivated Influenza Vaccine (SD-IIV) Sponsors: Kaiser Permanente; Sanofi Pasteur, a Sanofi Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials